Based on a study in Pakistan [66], the level of HbF is significantly increased in patients with intermediate thalassemia (around 8%) compared with that in thalassemia major patients, with the T allele in XMN1-HBG2 frequently present in the intermediate group. This evidence concerns the gene HBG2 and thalassemia.